Professor of Pediatrics
Children's Mercy Hospital
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Dr. Jennifer Goldman, MD, MSCR is a Professor of Pediatrics at the University of Missouri – Kansas City with appointments in the Divisions of Pediatric Infectious Diseases and Clinical Pharmacology at Children’s Mercy Kansas City. Her clinical and research efforts are centered around individualizing antimicrobial treatment in children to avoid the unintended consequences of anti-infectives. She is investigating potential biomarkers that may predict and prevent severe adverse drug reactions. She works with an amazing team to identify underreported adverse drug reactions, determine the epidemiology of these reactions, and investigate the biochemical and genetic factors associated with reaction risk. She currently serves as the Pediatric Health Organization Representative on the Pediatric Advisory Committee for the Food and Drug Administration and as a member of the American Academy of Pediatrics Committee on Drugs. During the COVID-19 pandemic, she began working with educational systems serving as a regional expert related to COVID-19 with a focus on the well-being of children and how to help facilitate a safe return to school. She has ongoing support from the NIH to help determine how diagnostic testing including COVID-19 can effectively be integrated into schools and is currently working with the Centers for Disease Control and Prevention to understand the epidemiology of respiratory viral infections in K-12 schools. She is a strong advocate for training the next generation of physician-researchers and serves as the co-lead on two NIH supported training grants.
